Clinical Trial Supply Services
At the center of every clinical trial is a patient waiting for a treatment to arrive safely, securely, and on time. Clinical trial supply services make that possible by ensuring investigational medicinal products (IMPs) are packaged, labeled, stored, and distributed in full regulatory compliance across global study sites
Patheon pharma services provides end-to-end clinical trial supply services for biotech and biopharma companies, helping sponsors protect patient safety while maintaining study timelines and operational control. Every step of the clinical supply chain directly impacts patient access to investigational therapies.
Our integrated clinical supply solutions deliver patient-ready materials with precision, visibility, and reliability across all phases of development.
Download our interactive infographic to explore Thermo Fisher's end-to-end clinical trial service capabilities.
Key clinical trial supply highlights
- 30 purpose-built, global cGMP facilities
- Over 35 years of clinical supply experience
- More than 560,000 clinical shipments in 2024
- 3,900+ clinical studies supported via clinical supply in 2024
More than 35 years of supporting patients through clinical supply
Formerly known as Fisher Clinical Services, our global clinical supply organization brings more than 35 years of experience supporting small molecules, biologics, and advanced therapies. This legacy of expertise ensures dependable clinical supply management focused on advancing research and protecting patients worldwide.
What factors define the right clinical trial supply partner?
Selecting a clinical supply partner requires evaluating:
- CGMP compliance
- Global facility coverage
- Cold chain capabilities
- Regulatory expertise
- End-to-end service integration
Our downloadable eBook outlines essential criteria biotech and biopharma companies should assess to ensure dependable global delivery of patient-ready investigational products across clinical trials.